Zacks Investment Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q2
Sell
-16,424
Closed -$161K 774
2015
Q1
$161K Buy
+16,424
New +$161K 0.01% 606